NDC 70752-171
PROPYLTHIOURACIL
Propylthiouracil
PROPYLTHIOURACIL is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Quagen Pharmaceuticals Llc. The primary component is Propylthiouracil.
| Product ID | 70752-171_d32ed2a1-db86-4000-a306-237a2f425fcb |
| NDC | 70752-171 |
| Product Type | Human Prescription Drug |
| Proprietary Name | PROPYLTHIOURACIL |
| Generic Name | Propylthiouracil |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-03-18 |
| Marketing Category | ANDA / |
| Application Number | ANDA080154 |
| Labeler Name | QUAGEN PHARMACEUTICALS LLC |
| Substance Name | PROPYLTHIOURACIL |
| Active Ingredient Strength | 50 mg/1 |
| Pharm Classes | Thyroid Hormone Synthesis Inhibitor [EPC],Thyroid Hormone Synthesis Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |